Lei Wu
- Cancer Research top 1%
- Cancer-related molecular mechanisms research 37
- MicroRNA in disease regulation 19
- Immunology top 2%
- Immune cells in cancer 14
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 18
- Molecular Biology top 5%
- RNA modifications and cancer 24
- Circular RNAs in diseases 18
- Epigenetics and DNA Methylation 15
- Biomaterials top 10%
-
- Ferroptosis and cancer prognosis 14
- Cited by
- Cancer ResearchImmunologyOncology
- Journals
- Nature Communications (2 papers)SHILAP Revista de lepidopterología (1 paper)PLoS ONE (2 papers)
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Lei Wu
158 papers receiving 4.2k citations
Hit Papers
Peers
Comparison fields: 5 of 133
- Cancer Research 1.3k
- Immunology 1.2k
- Oncology 1.1k
- Molecular Biology 2.4k
- Biomaterials 174
Countries citing papers authored by Lei Wu
This map shows the geographic impact of Lei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wu more than expected).
Fields of papers citing papers by Lei Wu
This network shows the impact of papers produced by Lei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wu. The network helps show where Lei Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 16 | |
| 6 | 2024 | 0 | |
| 7 | 2023 | 15 | |
| 8 | 2023 | 9 | |
| 9 | 2023 | 9 | |
| 10 | 2023 | 15 | |
| 11 | 2023 | 1 | |
| 12 | 2023 | 5 | |
| 13 | 2022 | 7 | |
| 14 | 2021 | 12 | |
| 15 | 2020 | 19 | |
| 16 | Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells | 2020 | 9 |
| 17 | 2020 | 39 | |
| 18 | Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasisbreakdown → | 2020 | 307 |
| 19 | 2019 | 164 | |
| 20 | 2018 | 6 |
About Lei Wu
Lei Wu is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 171 papers that have together received 4.3k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (37 papers), RNA modifications and cancer (24 papers), MicroRNA in disease regulation (19 papers), Cancer Immunotherapy and Biomarkers (18 papers), Circular RNAs in diseases (18 papers), Epigenetics and DNA Methylation (15 papers), Ferroptosis and cancer prognosis (14 papers) and Immune cells in cancer (14 papers). The work is most often cited by research in Cancer Research (1.3k citations), Immunology (1.2k citations) and Oncology (1.1k citations). Lei Wu has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Zhi‐Jun Sun, Wen‐Feng Zhang, Guang‐Tao Yu, Liang Mao, Lin‐Lin Bu, Wei‐Wei Deng, Lili Yang, Leilei Yang, Cong‐Fa Huang and Yicun Li. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.